DEF 14ASNDXCIK 0001395937
Syndax Pharmaceuticals Inc
Proxy statement (DEF 14A) filed .
Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.
New to the DEF 14A? What it is and how to read oneFiling facts
- Accession number
- 0000950170-24-040099
- Filer
- Syndax Pharmaceuticals Inc
- Ticker
- SNDX
- CIK
- 0001395937
- Form type
- DEF 14A
- Form description
- Proxy statement
- Filed at
- April 2, 2024
- Period of report
- March 27, 2024
- Filing size
- 6.2 MB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from Syndax Pharmaceuticals Inc
See all 42 filings from Syndax Pharmaceuticals Inc →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1395937/000095017024040099/0000950170-24-040099-index.htm ↗Filer's full EDGAR submission history
EDGAR · Syndax Pharmaceuticals Inc (0001395937) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.